A detailed history of Lmr Partners LLP transactions in Axonics, Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 269,863 shares of AXNX stock, worth $19.2 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
269,863
Previous 398,564 32.29%
Holding current value
$19.2 Million
Previous $26.8 Million 29.83%
% of portfolio
0.17%
Previous 0.26%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$67.3 - $69.67 $8.66 Million - $8.97 Million
-128,701 Reduced 32.29%
269,863 $18.8 Million
Q2 2024

Aug 14, 2024

BUY
$66.47 - $69.65 $23.4 Million - $24.5 Million
352,458 Added 764.45%
398,564 $26.8 Million
Q1 2024

May 15, 2024

BUY
$56.67 - $69.36 $2.61 Million - $3.2 Million
46,106 New
46,106 $3.18 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.